We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · November 19, 2022

Safety and Efficacy of Liquid AbobotulinumtoxinA in the Treatment of Glabellar Lines

Dermatologic Surgery


Additional Info

Dermatologic Surgery
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment
Dermatol Surg 2022 Nov 01;48(11)1198-1202, S Hilton, P Kestemont, G Sattler, M Volteau, C Thompson, B Andriopoulos, I Prygova, AK Berg, B Ascher

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading